Elevance Health Inc.

NYSE: ELV · Real-Time Price · USD
295.37
0.94 (0.32%)
At close: Aug 14, 2025, 3:59 PM
308.94
4.59%
Pre-market: Aug 15, 2025, 07:35 AM EDT

Elevance Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
176.81B 171.34B 156.59B 138.64B
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
176.81B 171.34B 156.59B 138.64B
Operating Income
7.9B 7.71B 7.6B 8B
Interest Income
n/a n/a n/a n/a
Pretax Income
7.9B 7.71B 7.6B 8B
Net Income
5.98B 5.99B 5.89B 6.16B
Selling & General & Admin
n/a n/a 17.69B 15.91B
Research & Development
n/a n/a n/a n/a
Other Expenses
168.91B 163.63B 131.31B 114.73B
Operating Expenses
168.91B 163.63B 149B 130.64B
Interest Expense
1.19B 1.03B 851M 798M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
168.91B 163.63B 149B 130.64B
Income Tax Expense
1.93B 1.72B 1.71B 1.85B
Shares Outstanding (Basic)
232.87M 233.07M 240M 243.8M
Shares Outstanding (Diluted)
232.9M 237.4M 242.8M 246.8M
EPS (Basic)
25.81 25.38 24.56 25.25
EPS (Diluted)
25.68 25.22 24.28 24.73
EBITDA
10.48B 10.49B 10.13B 10.1B
EBIT
9.09B 8.74B 8.45B 8.79B
Depreciation & Amortization
1.39B 1.75B 1.68B 1.3B